dijous, 27 d’abril del 2017

SurModics misses on Q2 earnings, narrows outlook

Surmodics Shares in SurModics (NSDQ:SRDX) fell today after the medical device maker missed earnings expectations on Wall Street with its 2nd quarter results and narrowed its full-year outlook.

The Eden Prairie, Minn.-based company posted profits of $506,000, or 4¢ per share, on sales of $17.5 million for the 3 months ended March 31, for bottom-line loss of -38% on sales growth of 5% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post SurModics misses on Q2 earnings, narrows outlook appeared first on MassDevice.



from MassDevice http://ift.tt/2qaeAYe

Cap comentari:

Publica un comentari a l'entrada